Method for determining the presence or absence of respiring cells on a three-dimensional scaffold

• US 6,967,086 B2
• Filed: 03/28/2002
• Issued: 11/22/2005
• Est. Priority Date: 04/18/1991
• Status: Expired due to Term

• Current Assignee: Becton, Dickinson & Co
• Original Assignee: Becton, Dickinson & Co
• Inventors: Liebmann-Vinson, Andrea, Heidaran, Mohammad A., Hemperly, John Jacob, Guarino, Richard David, Spargo, Catherine A.
• Primary Examiner(s): GITOMER, RALPH J
• Application Number:
  US10/109,475
• Publication Number:
  US 20020192636A1
• Time in Patent Office: 1,335 Days
• Field of Search: 435/34, 435/30, 435/1.1, 435/180, 435/395, 435/402, 435/405, 424/422, 424/425
• US Class Current: 435/34
• CPC Class Codes: B33Y 80/00 Products made by additive manufacturing
• CPC Class Codes: C12Q 1/04 Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor C12Q1/6897 takes precedence
• CPC Class Codes: C12Q 1/18 Testing for antimicrobial activity of a material
• CPC Class Codes: C12Q 2304/44 Oxygen

Abstract

The invention provides a method and apparatus for determining the presence or absence of respiring cells, involving combining a three-dimensional biomimetic scaffold and cells onto a sensor composition.

Claims

1. A method for determining presence or absence of respiring cells comprising:

(i) depositing a three-dimensional biomimetic scaffold and cells onto a sensor composition, said sensor composition comprising a luminescent compound that exhibits a change in luminescent property when irradiated with light containing wavelengths which cause said compound to luminesce upon exposure to oxygen;

(ii) irradiating said sensor composition with light to cause luminescence;

(iii) determining the resultant luminescent light intensity emitted;

(iv) determining, based on said emitted luminescent light intensity, the presence or absence of respiring cells.

2. The method of claim 1 wherein said determining in step iv further comprises comparing said resultant luminescent light intensity emitted to that of a control, wherein a change in luminescent property relative to the luminescent property of the control is indicative of the presence or absence of respiring cells.

3. The method of claim 2 wherein said comparing occurs in real time.

4. The method of claim 1 wherein said three-dimensional scaffold is opaque.

5. The method of claim 1 wherein said three-dimensional scaffold comprises biomimetic molecules selected from the group consisting of natural polymers, synthetic polymers, inorganic composites and combinations thereof.

6. The method of claim 1 wherein said three-dimensional scaffold comprises extracellular matrices.

7. The method of claim 6 wherein said extracellular matrix is collagen.

8. The method of claim 1 wherein said three-dimensional scaffold includes a composition comprising laminin, collagen IV, entactin, heparan sulfate proteoglycan, growth factors, matrix metalloproteinases, extracts from mouse sarcoma tumors and combinations thereof.

9. The method of claim 1 wherein the three dimensional scaffold comprises growth factors.

10. The method of claim 1 wherein the three-dimensional scaffold is non-covalently immobilized to the sensor composition.

11. The method of claim 1 wherein said luminescent compound is contained within a matrix which is relatively impermeable to water and non-gaseous solutes, but which is permeable to oxygen.

12. The method of claim 11 wherein said matrix is an elastomer or plastic matrix.

13. The method of claim 11 wherein said matrix is a silicone elastomer matrix.

14. The method of claim 1 wherein said luminescent compound is adsorbed on solid silica particles.

15. The method of claim 1 wherein said luminescent compound is a tris-4,7-diphenyl-1,10-phenanthroline ruthenium (II) salt.

16. The method of claim 15 wherein said luminescent compound is a tris-4,7-diphenyl-1,10-phenanthroline ruthenium (II) chloride.

17. The method of claim 1 wherein said luminescent compound is a tris-2,2′

-bipyridyl ruthenium (II) salt.

18. The method of claim 17 wherein said luminescent compound is tris-2,2′

bipyridyl ruthenium (II) chloride hexahydrate.

19. The method of claim 1 wherein said luminescent compound is 9,10-diphenyl anthracene.

20. The method of claim 1 wherein said cells are isolated from atmospheric oxygen.

21. The method of claim 1 wherein said cells are exposed to atmospheric oxygen.